Journals / Damar Cerrahi Dergisi / 2016 / Cilt: 25 - Sayı: 1

Kritik Bacak İskemisinde İnfrapopliteal Anjiyoplasti

Infrapoplıteal Angioplasty In Critical Limb Ischemia

Pages
11–16
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

With increased experience in infrapopliteal angioplasty and new catheter technology, better results are expected considering limb salvage and survey in the near future.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Ruthetherford category 4 and more severe symptomatic patients are regarded as critical limb ischemia (CLI).
📊
Key Findings & Data:The results of infrapopliteal angioplasty is still debated in CLI patients in our country.Material and Methods: Between May 2009 and June 2015, infrapopliteal angioplasty was performed in 34 CLI patients, and cross-sectional results were collected for this study.Results: Percutaneous transluminal angioplasty (PTA) was performed for revascularization of 65 lesions in 37 limbs as the first line treatment option.
💡
Conclusion & Impact:With increased experience in infrapopliteal angioplasty and new catheter technology, better results are expected considering limb salvage and survey in the near future.
🔬Design:Survey & Empirical Study
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Ruthetherford category 4 and more severe symptomatic patients are regarded as critical limb ischemia (CLI). Owing to the advances in catheterization equipment and angiography techniques, more aggressive infrapopliteal interventions may be succesfully performed. The results of infrapopliteal angioplasty is still debated in CLI patients in our country.Material and Methods: Between May 2009 and June 2015, infrapopliteal angioplasty was performed in 34 CLI patients, and cross-sectional results were collected for this study.Results: Percutaneous transluminal angioplasty (PTA) was performed for revascularization of 65 lesions in 37 limbs as the first line treatment option. At first intervention, 73% of the extremities were successfully revascularized. Limb salvage and survey rates at the end of 2 years were calculated as 93% and 78%, respectively.Conclusion: Nowadays PTA yields equivalent results to surgery, and it can be applied as the first line therapy in CLI patients. With increased experience in infrapopliteal angioplasty and new catheter technology, better results are expected considering limb salvage and survey in the near future.

Özet

Amaç: Rutherford kategori 4 ve üzeri semptomatik belirtileri olan hastalar kritik bacak iskemisi (KBİ) olarak kabul edilmektedir. Kateter ve anjiyografi tekniklerindeki gelişmelere paralel olarak infrapopliteal girişim sayı ve niteliği artmıştır. Ülkemizde infrapopliteal girişimlerin sonuçlarını inceleyen çalışmalara ihtiyaç vardır.Gereç ve Yöntemler: Mayıs 2009 ve Haziran 2015 tarihleri arasında infrapopliteal girişim uygulanan 34 kritik bacak iskemisi hastasının sonuçları kesitsel olarak incelendi.Bulgular: Toplam 37 ekstremitede bulunan 65 lezyona perkütan transluminal anjiyoplasti (PTA) ilk seçenek tedavi olarak uygulandı. İlk girişim ile revaskülarizasyon oranı %73 olarak gerçekleşirken, 2 yıllık ekstremite kurtarma ve sağ kalım oranı sırasıyla %93 ve %78 olarak gerçekleşti.Sonuç: KBİ olgularında cerrahiye eşdeğer sonuçlar elde edilebilen PTA ilk seçenek tedavi olarak düşünülmelidir. Yeni kateterler ve infrapopliteal deneyim artışına paralel olarak gelecekte ilk girişim başarı ve ekstremite kurtarma oranında çok daha iyi sonuçlar elde edilebilecektir.

🔖

Cite This Article

KAHRAMAN, D., ŞIRLAKB, M. (2022). Kritik Bacak İskemisinde İnfrapopliteal Anjiyoplasti. Damar Cerrahi Dergisi, Cilt: 25 - Sayı: 1, 11–16. https://ajindex.com/articles/486675

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Simons JP, Goodney PP, Flahive J, Hoel AW,Hallett JW, Kraiss LW, et al. A comparativeevaluation of risk-adjustment models forbenchmarking amputation-free survival afterlower extremity bypass. J Vasc Surg2016;63(4):990-7
  2. Conte MS. Bypass versus Angioplasty in Se-vere Ischaemia of the Leg (BASIL) and the(hoped for) dawn of evidence-based treatmentfor advanced limb ischemia. J Vasc Surg.2010;51(5Suppl):69S-75S
  3. Schreve MA, Minnee RC, Bosma J, Lei-jdekkers VJ, Idu MM, Vahl AC. Comparativestudy of venous arterialization and pedal by-pass in a patient cohort with critical limb is-chemia. Ann Vasc Surg 2014;28(5):1123-7
  4. Avgerinos ED, Sachdev U, Naddaf A, DoucedDR, Mohapatra A, Leers SA, et al. Autologousalternative veins may not provide better out-comes than prosthetic conduits for below-kneebypass when great saphenous vein is un-available. J Vasc Surg 2015;62(2):385-91
  5. Faglia E, Clerici G, Scatena A, Caminiti M,Curci V, Prisco M, et al. Severity of demo-graphic and clinical characteristics, revascu-larization feasibility, major amputation, andmortality rate in diabetic patients admitted to atertiary diabetic foot center for critical limb is-chemia: comparison of 2 cohorts recruited ata 10-year distance. Ann Vasc Surg.2014;28(7):1729-36
  6. Bisdas T, Borowski M, Torsello G, First-LineTreatments in Patients With Critical Limb Is-chemia (CRITISCH) Collaborators. Currentpractice of first-line treatment strategies in pa-tient with critical limb ischemia. J Vasc Surg.2015;62(4):965-73
  7. Plecha FR, Bertin VJ, Plecha EJ, Avellone JC,Farrell CJ, Hertzer NR, et al. The early resultsof vascular surgery in patients 75 years of ageor older: an analysis of 3259 cases. J VascSurg 1985;2(6):769-74
  8. Söderström MI, Arvela EM, Korhonen M,Halmesmäki KH, Albäck AN, Biancari F, et al.Infrapopliteal percutaneous transluminal an-gioplasty versus bypass surgery as first-linestrategies in critical leg ischemia: a propensityscore analysis. Ann Surg 2010;252(5):765-73
  9. Shishehbor MH. Acute and critical limb is-chemia: when time is limb. Cleve Clin J Med2014;81(4):209-16
  10. Rutherford RB, Baker JD, Ernst C, JohnstonKW, Porter JM, Ahn S, et al. Recommendedstandards for reports dealing with lower ex-tremity ischemia: revised version. J Vasc Surg1997;26(3):517-38
  11. Adam DJ, Beard JD, Cleveland T, Bell J,Bradbury AW, Forbes JF, et al. Bypass ver-sus angioplasty in severe ischaemia of theleg(BASIL): multicentre, randomised con-trolled trial. Lancet 2005;366(9501):1